Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels (Q50092593)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2006

Language	Label	Description	Also known as
English	Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels	scientific article published in January 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

11

object named as

Eiji Ishimura

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

14

object named as

Masaaki Inaba

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

author name string

Takehisa Kawata

1

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Yasuo Imanishi

2

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Keisuke Kobayashi

3

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Naoyoshi Onoda

4

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Senji Okuno

5

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Yoshiaki Takemoto

6

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Takeshi Komo

7

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Hideki Tahara

8

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Michihito Wada

9

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Nobuo Nagano

10

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Takami Miki

12

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Tetsuro Ishikawa

13

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Yoshiki Nishizawa

15

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Journal of Bone and Mineral Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

24

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

4

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

300-306

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal Chromosomal Defects in the Molecular Pathogenesis of Refractory Hyperparathyroidism of Uremia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel Chromosomal Abnormalities Identified by Comparative Genomic Hybridization in Parathyroid Adenomas1

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation and action of the calcium-sensing receptor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for both abnormal set point of PTH stimulation by calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased biological potency of hexafluorinated analogs of 1,25-dihydroxyvitamin D3 on bovine parathyroid cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of polyamines in the proliferation of bovine parathyroid cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16816924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00774-006-0687-Y

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/16816924

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50092593&oldid=2255278726"